col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

85 Results       Page 1

  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―25 153P Evaluation of chemoradiotherapy-induced radiation pneumonia in non-small cell lung cancer patients with a history of the human coronavirus disease 2019 (COVID-19) U. Nabizade
2 [GO] 2024―Mar―25 93P Real-world analysis of first-line maintenance (1LM) immunotherapy (IO) ± pemetrexed for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic A.R. Minchom, N. Gilding, V. Tan, K. Christoforou, J. Rule, A. Aziez, et al. (+2)
3 [GO] 2024―Mar―25 156P The impact of the COVID-19 pandemic on the treatment patterns of patients with stage III unresectable non-small cell lung cancer P. Borghetti, K. Hsieh, B. Al-Khalidi, S. Kumar Adepu, D. Sanchez-Hernandez, L. Cai, et al. (+3)
4 [GO] 2023―Jun―21 Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors S.F. Oosting, A.A.M. van der Veldt, R.S.N. Fehrmann, A. Bhattacharya, R.S. van Binnendijk, C.H. GeurtsvanKessel, et al. (+17)
5 [GO] 2023―Jun―19 Learning Lessons from the COVID-19 pandemic for Real World Evidence research in Oncology - shared perspectives from an international consortia Luís Castelo-Branco, Rebecca Lee, Mariana Brandão, Alessio Cortellini, André Freitas, Marina Garassino, et al. (+10)
6 [GO] 2023―May―31 Tobacco cessation and the role of ESMO and medical oncologists: addressing the specific needs of cancer patients in times of the COVID-19 pandemic R. Krech, S. Peters, H. Kroemer, D. Fu, R. Giuliani, J. Sehouli, et al. (+3)
7 [GO] 2023―May―15 275P Serological response to COVID-19 vaccine in patients with advanced breast cancer P. Casado Cuesta, F. Pikabea Díaz, E. Galve-Calvo, A. Zumarraga, A. Bilbao Penas, B. López De San Vicente, et al. (+14)
8 [GO] 2023―May―15 271P Impact of COVID-19 vaccination on health-related quality of life in patients with breast cancer M. Forster, R. Würstlein, A. Koenig, A. Stefan, E. Wiegershausen, S. Mahner, et al. (+2)
9 [GO] 2023―May―04 COVID-19 in cancer patients: Update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases Pierre Martin, Zoi Tsourti, Joana Ribeiro, Luis Castelo-Branco, Evandro de Azambuja, Spyridon Gennatas, et al. (+19)
10 [GO] 2023―Apr―25 Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort Maximilian J. Mair, Manfred Mitterer, Thomas Buratti, Luzia Berchtold, Dominic Fong, Matthias Preusser
11 [GO] 2023―Apr―03 Vaccination for seasonal flu, pneumococcal infection, and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) Paolo Pedrazzoli, Angioletta Lasagna, Irene Cassaniti, Antonio Piralla, Andrea Squeri, Raffaele Bruno, et al. (+6)
12 [GO] 2023―Mar―22 67P Detrimental effect of the COVID-19 pandemic on patients with adult extremity bone sarcoma: Reference center experience P. Teterycz, B. Szostakowski, M. Rosinska, H.M. Kosela Paterczyk, P. Rutkowski
13 [GO] 2023―Feb―25 77P The impact of COVID-19 on gynecological cancer diagnoses in Greece O. Fiste, P. Iliopoulou, K. Tzannis, C. Theofanakis, A. Rouvali, C. Markellos, et al. (+14)
14 [GO] 2023―Feb―25 13P Cervical cancer screening in a basic health unit in South of Brazil: Impact of the COVID-19 pandemic I.F. Michelon, I. Silveira Pinheiro, M.E. Ayres Obelar, A. Teixeira, C. Amaral, F. Nedel
15 [GO] 2023―Feb―25 79P The situation of gynecological cancer before and after COVID-19 pandemic years in Kosovo B. Profka, D. Berberi
16 [GO] 2023―Jan―10 One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment A.A.M. van der Veldt, S.F. Oosting, R.S.N. Fehrmann, C.H. GeurtsvanKessel, R.S. van Binnendijk, A.-M.C. Dingemans, et al. (+17)
17 [GO] 2022―Dec―30 PP088 The case fatality rate of COVID-19 infection in non-small cell lung cancer Y.J. Jung, S.H. Park, H.A. Jung, J-M. Sun, S-H. Lee, J.S. Ahn, M-J. Ahn
18 [GO] 2022―Dec―30 OP12 Durability and immunogenicity after two doses of ChAdOx1 nCov-19 among the type of cancer treatment in oncologic patients: A prospective, multicenter observational study P. Wanchaijiraboon, N. Teeyapun, S. Luangdilok, N. Wanlapakorn, P. Sainamthip, N. Pakvisal, et al. (+11)
19 [GO] 2022―Nov―07 Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future T. Geukens, M. Brandão, A. Laenen, J. Collignon, C. Van Marcke, I. Louviaux, et al. (+22)
20 [GO] 2022―Aug―24 Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment Elena Su, Stefanie Fischer, Ruth Demmer-Steingruber, Susanne Nigg, Sabine Güsewell, Werner C. Albrich, et al. (+3)
21 [GO] 2022―Jul―01 Trials without borders - decentralized trials and ensuring access to novel cancer therapies during a global pandemic Aaron C. Tan, Tira J.Y. Tan, Stephanie P.L. Saw, Justina Y.C. Lam, Yoon Sim Yap, Wan-Teck Lim, et al. (+3)
22 [GO] 2022―Jun―23 Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera Statement. Giordano D. Beretta, Raffaella Casolino, Domenico C. Corsi, Francesco Perrone, Massimo Di Maio, Saverio Cinieri, et al. (+6)
23 [GO] 2022―May―08 COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO CoCARE) Luis Castelo-Branco, Zoi Tsourti, Spyridon Gennatas, Jacobo Rogado, Marina Sekacheva, David Viñal, et al. (+22)
24 [GO] 2022―Apr―14 Cancer diagnosis in Catalonia (Spain) after two years of COVID-19 pandemic: an incomplete recovery Ribes J, Pareja L, Sanz X, Mosteiro S, Escribà JM, Esteban L, et al. (+5)
25 [GO] 2022―Apr―01 Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’ L. Cantini, G. Mentrasti, G. Lo Russo, D. Signorelli, G. Pasello, E. Rijavec, et al. (+56)
26 [GO] 2022―Mar―07 Androgen deprivation therapy and cognitive decline in the NEON-PC prospective study, during the COVID-19 pandemic. Natália Araújo, Adriana Costa, Luisa Lopes-Conceição, Augusto Ferreira, Filipa Carneiro, Jorge Oliveira, et al. (+7)
27 [GO] 2022―Mar―02 Postgraduate oncology educational shifts during the COVID-19 pandemic: results of faculty and medical student surveys Antoine Moya-Plana, Lambros Tselikas, Olivier Lambotte, Stephane Temam, Thierry De Baere, Eric Deutsch, et al. (+3)
28 [GO] 2022―Feb―10 Outcomes of patients with cancer infected with SARS-CoV-2: results from the Ion Chiricuță Oncology Institute series Paul Kubelac, Alexandra Preda, Tudor Ciuleanu, Nicolae Todor, Ovidiu Balacescu, Patriciu Achimas-Cadariu, et al. (+7)
29 [GO] 2022―Feb―07 Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients P.A. van Dam, Y. Debie, L. Teuwen, L. Verbruggen, G. Vanhoutte, B. Peeters, et al. (+5)
30 [GO] 2022―Feb―03 Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario Luca Cantini, Giulia Mentrasti, Giuseppe Lo Russo, Diego Signorelli, Giulia Pasello, Erika Rijavec, et al. (+56)
31 [GO] 2022―Jan―28 Managing hematological cancer patients during the COVID-19 pandemic: An ESMO-EHA Interdisciplinary Expert Consensus Christian Buske, Martin Dreyling, Alberto Alvarez-Larrán, Jane Apperley, Luca Arcaini, Caroline Besson, et al. (+30)
32 [GO] 2021―Dec―17 The impact of COVID-19 on oncology professionals - one year on: lessons learned from the ESMO Resilience Task Force survey series Kok Haw Jonathan Lim, Krithika Murali, Eleanor Thorne, Kevin Punie, Konstantinos Kamposioras, Christoph Oing, et al. (+11)
33 [GO] 2021―Nov―27 Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study E.M. Ruggeri, F. Nelli, A. Fabbri, A. Onorato, D. Giannarelli, J. R. Giron Berrios, et al. (+12)
34 [GO] 2021―Nov―23 The impact of COVID-19 on cancer care and oncology clinical research: an experts’ perspective Cristiana Sessa, Jorge Cortes, Pierfranco Conte, Fatima Cardoso, Toni Choueiri, Reinhardt Dummer, et al. (+9)
35 [GO] 2021―Sep―27 Serologic Response to COVID-19 Infection and/or Vaccine in Cancer Patients on Active Treatment Albert Grinshpun, Yakir Rottenberg, Iddo Z. Ben-Dov, Esther Djian, Dana G. Wolf, Luna Kadouri
36 [GO] 2021―Sep―08 REDUCED HUMORAL IMMUNE RESPONSE AFTER BNT162B2 COVID-19 MRNA VACCINATION IN CANCER PATIENTS UNDER ANTI-NEOPLASTIC TREATMENT M. Peeters, L. Verbruggen, L. Teuwen, G. Vanhoutte, S. Vande Kerckhove, B. Peeters, et al. (+16)
37 [GO] 2021―Jul―26 Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM) P. Jiménez-Labaig, V. Pacheco-Barcia, A. Cebrià, F. Gálvez, B. Obispo, D. Páez, et al. (+18)
38 [GO] 2021―Jul―24 Beyond the lessons learned from the Covid19 pandemic: Opportunities to optimize clinical trial implementation in oncology Luis Castelo-Branco, Ahmad Awada, George Pentheroudakis, Jose Luis Perez-Garcia, Joaquin Mateo, Giuseppe Curigliano, et al. (+6)
39 [GO] 2021―Jul―09 Impact of COVID-19 on Cancer Service Delivery; a follow up international survey of oncology clinicians Grace Chazan, Fanny Franchini, Marliese Alexander, Susana Banerjee, Linda Mileshkin, Prunella Blinman, et al. (+9)
40 [GO] 2021―Jul―01 The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II K.H.J. Lim, K. Murali, K. Kamposioras, K. Punie, C. Oing, M. O’Connor, et al. (+10)
41 [GO] 2021―Jun―11 Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis Hanna M. Peacock, Tim Tambuyzer, Freija Verdoodt, Frédéric Calay, Hélène A. Poirel, Harlinde De Schutter, et al. (+3)
42 [GO] 2021―Jun―02 The COVID-19 pandemic could be a setback for gender equality in oncology-and a key moment to push ahead with transformative policies A. Cervantes
43 [GO] 2021―May―27 COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC) F. Bianchi, E. Dama, F. Di Nicolantonio, G. Baldassarre, I. Guerriero, E. Torchiaro, et al. (+7)
44 [GO] 2021―May―25 Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey P. Garrido, A.A. Adjei, J. Bajpai, S. Banerjee, A.S. Berghoff, S.P. Choo, et al. (+12)
45 [GO] 2021―Apr―30 Impact of the COVID-19 pandemic on the care of cancer patients in Spain Mariluz Amador, Xavier Matias-Guiu, Gemma Sancho-Pardo, Jorge Contreras Martinez, Julio C. de la Torre-Montero, Angeles Peñuelas Saiz, et al. (+4)
46 [GO] 2021―Apr―19 Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France J.Y. Blay, S. Boucher, B. Le Vu, C. Cropet, S. Chabaud, D. Perol, et al. (+27)
47 [GO] 2021―Apr―08 The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer Gino M. Dettorre, Meera Patel, Alessandra Gennari, George Pentheroudakis, Emanuela Romano, Alessio Cortellini, David J. Pinato
48 [GO] 2021―Apr―07 Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network G. Morgan, M. Tagliamento, M. Lambertini, B. Devnani, B. Westphalen, R. Dienstmann, et al. (+12)
49 [GO] 2021―Mar―20 COVID-19 Infection in Cancer Patients: What has been the Contribution of Associazione Italiana Oncologia Medica (AIOM) to Oncological Care Since the Beginning of the First Pandemic Wave? Nicola Silvestris, Massimo Di Maio, Antonio Russo, Rita Chiari, Ugo De Giorgi, Lucia Del Mastro, et al. (+6)
50 [GO] 2021―Feb―06 The impact of COVID-19 on oncology professionals: Results of the ESMO Resilience Task Force survey collaboration Susana Banerjee, Kok Haw Jonathan Lim, Krithika Murali, Konstantinos Kamposioras, Kevin Punie, Christoph Oing, et al. (+10)
51 [GO] 2021―Jan―28 Erratum to ‘Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome’ R.J. Lee, O. Wysocki, T. Bhogal, R. Shotton, A. Tivey, A. Angelakas, et al. (+34)
52 [GO] 2021―Jan―15 Social distress among Medical Oncologists and other Health Care Professionals during the first wave of COVID-19 pandemic in Italy R. Berardi, M. Torniai, M.S. Cona, F. Cecere, R. Chiari, V. Guarneri, et al. (+6)
53 [GO] 2021―Jan―05 Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey A.S. Gheorghe, Ş.M. Negru, C. Nițipir, L. Mazilu, M. Marinca, B. Gafton, et al. (+11)
54 [GO] 2021―Jan―05 Supportive care in patients with cancer during the COVID-19 pandemic Matti Aapro, Gary H. Lyman, Carsten Bokemeyer, Bernardo L. Rapoport, Nicola Mathieson, Natalia Koptelova, et al. (+4)
55 [GO] 2021―Jan―05 Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future P. Hofman, M. Ilié, E. Chamorey, P. Brest, R. Schiappa, V. Nakache, et al. (+74)
56 [GO] 2021―Jan―05 Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome R.J. Lee, O. Wysocki, T. Bhogal, R. Shotton, A. Tivey, A. Angelakas, et al. (+34)
57 [GO] 2020―Dec―01 Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians Grace Chazan, Fanny Franchini, Marliese Alexander, Susana Banerjee, Linda Mileshkin, Prunella Blinman, et al. (+9)
58 [GO] 2020―Nov―06 COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study Federico Nichetti, Marta Bini, Margherita Ambrosini, Arianna Ottini, Alessandro Rametta, Rita Leporati, et al. (+5)
59 [GO] 2020―Oct―23 Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy Dawid Sigorski, Paweł Sobczuk, Małgorzata Osmola, Kamil Kuć, Anna Walerzak, Michal Wilk, et al. (+7)
60 [GO] 2020―Oct―22 Correction: Oncological care organisation during COVID-19 outbreak
61 [GO] 2020―Oct―13 Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change? Domenica Lorusso, Isabelle Ray-Coquard, Ana Oaknin, Susana Banerjee
62 [GO] 2020―Sep―25 Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis Evandro de Azambuja, Mariana Brandão, Hans Wildiers, Annouschka Laenen, Sandrine Aspeslagh, Christel Fontaine, et al. (+12)
63 [GO] 2020―Sep―21 Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era Grazia Arpino, Carmine De Angelis, Pietro De Placido, Erica Pietroluongo, Luigi Formisano, Roberto Bianco, et al. (+9)
64 [GO] 2020―Sep―02 SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic Thorsten Fuereder, Anna Sophie Berghoff, Gerwin Heller, Helmuth Haslacher, Thomas Perkmann, Robert Strassl, et al. (+10)
65 [GO] 2020―Aug―27 Oncological care organisation during COVID-19 outbreak Concetta Elisa Onesti, Hope S Rugo, Daniele Generali, Marc Peeters, Khalil Zaman, Hans Wildiers, et al. (+19)
66 [GO] 2020―Jul―27 ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies Ilaria Colombo, Eleonora Zaccarelli, Maria Del Grande, Federica Tomao, Francesco Multinu, Ilaria Betella, et al. (+4)
67 [GO] 2020―Jul―15 Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma Stefanie Aeppli, Eric Innocents Eboulet, Tim Eisen, Bernard Escudier, Stefanie Fischer, James Larkin, et al. (+9)
68 [GO] 2020―Jul―13 Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy? Alberto Zambelli, Carlo Alberto Tondini
69 [GO] 2020―Jun―24 ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer Antonio Passaro, Alfredo Addeo, Christophe Von Garnier, Fiona Blackhall, David Planchard, Enriqueta Felip, et al. (+5)
70 [GO] 2020―Jun―22 Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform Marc Peeters, Peter van Dam, Marika Anna Rasschaert, Christof Vulsteke, Sven De Keersmaecker, Lieselot Croes, et al. (+4)
71 [GO] 2020―Jun―22 Impact of the COVID-19 outbreak on cancer patient flow and management: experience from a large university hospital in Spain Luis Manso, Guillermo De Velasco, Luis Paz-Ares
72 [GO] 2020―Jun―11 Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy Dominic Fong, Simon Rauch, Christian Petter, Eva Haspinger, Monika Alber, Manfred Mitterer
73 [GO] 2020―May―26 ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer Loredana Vecchione, Sebastian Stintzing, George Pentheroudakis, Jean-Yves Douillard, Florian Lordick
74 [GO] 2020―May―26 Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration Carlo Palmieri, Daniel Palmer, Peter JM Openshaw, J Kenneth Baille, Malcolm G Semple, Lance Turtle
75 [GO] 2020―May―21 ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer Evandro de Azambuja, Dario Trapani, Sibylle Loibl, Suzette Delaloge, Elzbieta Senkus, Carmen Criscitiello, et al. (+7)
76 [GO] 2020―May―18 ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer Silvia Catanese, George Pentheroudakis, Jean-Yves Douillard, Florian Lordick
77 [GO] 2020―May―14 How we treat patients with brain tumour during the COVID-19 pandemic Michael Weller, Matthias Preusser
78 [GO] 2020―May―14 How we treat patients with lung cancer during the SARS-CoV-2 pandemic Mariano Provencio, Alberto Ruano-Raviña
79 [GO] 2020―May―12 Brief letter of a doctor to his psychologist in the COVID-19 outbreak era Daniele Santini, Giuseppe Tonini
80 [GO] 2020―May―07 Call for ensuring cancer care continuity during COVID-19 pandemic Marco Tagliamento, Matteo Lambertini, Carlo Genova, Emanuela Barisione, Andrea De Maria, Marco Grosso, et al. (+5)
81 [GO] 2020―May―04 Editorial debate: Challenges an oncologist has to face during the SARS-CoV-2 pandemic within a universal healthcare system Camillo Porta
82 [GO] 2020―Apr―30 Indications regarding the management of interventional clinical trials with drugs during the current COVID-19 emergency in Italy Carmine Pinto, Celeste Cagnazzo
83 [GO] 2020―Apr―15 Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists Icro Meattini, Pierfrancesco Franco, Liliana Belgioia, Luca Boldrini, Angela Botticella, Maria Carmen De Santis, et al. (+6)
84 [GO] 2020―Apr―03 How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere Giuseppe Banna, Alessandra Curioni-Fontecedro, Alex Friedlaender, Alfredo Addeo
85 [GO] 2020―Mar―30 Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective Matteo Lambertini, Angela Toss, Antonio Passaro, Carmen Criscitiello, Chiara Cremolini, Claudia Cardone, et al. (+7)

85 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.015 sec